Improvement of Lower Digestive Endoscopy Without Anesthesia : Evaluation of the Virtual Reality Mask
- Conditions
- Digestive System Disease
- Interventions
- Other: Standard of careDevice: Use of a VR mask
- Registration Number
- NCT06414239
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Brief Summary
90% of colonoscopies are performed with general anesthesia (GA). GA carries risks and requires a prior anesthesia consultation, a dedicated team and technical platform on the day of the examination. These constraints increase the time it takes to organize examinations. This was particularly highlighted during the recent health crisis. The success of colonoscopy without GA varies depending on the patient's experience of the examination. Any measure allowing better tolerance of the exam is therefore likely to increase its success rate and avoid rescheduling the exam under GA. A 2017 meta-analysis showed that the use of virtual reality (VR) reduced pain and anxiety during care for burn victims, in trauma and oncology. In upper digestive endoscopy, retrospective studies have shown good tolerability of the examinations and a reduction in pain compared to patients with only local anesthesia. Thus, if the VR mask improves the success rate of total colonoscopy by improving tolerance and acceptability, more examinations without GA could be considered. It could also have an economic impact.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 240
Patient over 18 years old with an indication for total colonoscopy and accepting without General Anesthesia
- Hearing problems or low vision
- Psychiatric or cognitive disorders hindering communication
- History of epilepsy
- Claustrophobia which can lead to a rejection of the virtual reality mask
- History of cybercynetosis during previous use of VR
- Chronic abdominal pain with baseline Visual analogue scale (VAS) > 5
- Emergency examination
- Patient participating in another interventional research on digestive endoscopy
- Patient not speaking French
- Patient under guardianship
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control group Standard of care Coloscopy without any premedication or anesthesia Interventional group Use of a VR mask Coloscopy with a virtual reality mask
- Primary Outcome Measures
Name Time Method Rate of cecal intubation At day 0 Success of a total colonoscopy defined by the rate of cecal intubation (visualization of the ileocecal valve and the appendicular orifice with the endoscope located near the appendicular orifice) or visualization of the ileocecal anastomosis in case of history of surgery removing the ileocaecal valve
- Secondary Outcome Measures
Name Time Method Maximum anxiety assessed by the patient by numerical scale At 1 month The scale varies from 0 to 10. 0 is no anxiety, 10 is the worst possible anxiety
Maximum pain assessed by the patient by numerical scale At 1 month The scale varies from 0 to 10. 0 is no pain, 10 is the worst possible pain
Duration of the examination At day 0 Time between introduction and removal of the colonoscope
Total duration of the procedure At day 0 time between entering and leaving the room
Number of minutes from visualization of the valve between the introduction of the colonoscope and 30 minutes maximum At day 0 Between the introduction of the colonoscope and 30 minutes maximum. It can be the ileum in the event of a history of surgery removing the valve.
Proportion of procedures where the VR mask is removed at the patient's request Up to 30 months Proportion of VR device malfunctions (≥ 1) during the procedure in the intervention group Up to 30 months Patient's opinion to repeat the examination under the same conditions At 1 month It will be assesses by the Likert scale
Proportion of colonoscopies with detection of at least one adenoma Up to 30 months Operator satisfaction Up to 30 months Assessed by the Analogue Visual Scale examination
Incremental cost effectiveness ratio or incremental cost-result ratio in the form of cost per additional colonoscopic success Up to 30 months